Evidence map›Paper›PMID 36432152›Full record

ArticleMolecules (Basel, Switzerland)2022

Ginsenoside Rb1 from

Wen-Tao Sun, Cindy L H Yang, Terry C T Or, Dan Luo, James C B Li

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Horticulture research · 2024
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wen-Tao SunSchool of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao 266071, China.
Cindy L H YangMolecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Terry C T OrMolecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Dan LuoMolecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
James C B LiDepartment of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-7156-0318
Chinese University of Hong Kong · HK

Funding

National Natural Science Foundation of China 82200440Shandong Provincial Natural Science Foundation ZR2022QH234
6 · The paper itself

Abstract

Chronic inflammation is commonly accompanied by the stimulation of matrix metalloproteinases (MMPs) production and the degradation of the extracellular matrix. The overexpression of MMP-9 (Gelatinase B) highly participates in the progression of pathetic cardiac remodeling and liver cancer metastasis.

Indexed as

Panax notoginsengeIF-2 KinaseGinsenosidesMatrix Metalloproteinase 9NF-kappa BTumor Necrosis Factor-alphaVentricular RemodelingeIF-2 Kinaseginsenoside Rb1GinsenosidesMatrix Metalloproteinase 9NF-kappa BTumor Necrosis Factor-alphadouble-strand RNA-dependent protein kinase (PKR)Ginsenoside Rb1matrix metalloproteinase 9NF-κBPanax notoginseng

Identifiers

PMID36432152
PMCPMC9692425
OpenAlexW4309717474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.